PubMed HealthSearch

PubMed · 6161332

Current techniques in chromosome analysis.

Abstract

New techniques in chromosome analysis provide more precision in the identification of chromosomal abnormalities than was previously possible. Specific small chromosome changes can now often be related to defined syndromes of mental retardation and congenital anomalies, or to malignant disease. Some aspects of chromosomal function can also be investigated cytologically, e.g., abnormalities in DNA repair, susceptibility to damaging agents, DNA replication sequences, and sites of inactive heterochromatin and of actively transcribing ribosomal DNA. Future trends will involve even finer resolution of the chromosomal bands, using both extended chromosomes and probes specific for small chromosomal regions, as well as continued localization of specific genes on the cytologic map.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D Warburton. 1980. Current techniques in chromosome analysis.. https://doi.org/10.1016/s0031-3955(16)33924-4

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

S-phase arrest of nutrient deprived lung cancer cells.

The human small cell lung cancer cell line NCI-H82 was used to study the effect of nutritional status on cell proliferative parameters. Incorporation of bromodeoxyuridine (BrdUrd) was used to characterize actively proliferating cells and to obtain information on cell cycle dynamics. During several days, in which the culture medium was not changed, a gradual decrease in overall cell growth, labeling index, and vitality was observed. Simultaneously, an increase in the number of S-phase cells that did not incorporate BrdUrd was noticed. From a more detailed kinetic study on d 6 of nutrient depletion, it appeared that, although the cells incorporated BrdUrd, they stopped cycling. When the same cells were regrown in fresh culture medium, a delay of 10 h in G1-phase entry and exit was measured. After this delay the cells resumed the cell cycle at normal phase transit rates. In addition, BrdUrd unlabeled S-phase cells were gradually lost from the culture. Bivariate flow cytometric DNA/proliferating cell nuclear antigen (PCNA) and DNA/Ki67-antigen analyses confirmed a delay in G1 phase entry and exit. In this paper we show that nutrient depletion can cause cell cycle arrest as indicated by the occurrence of BrdUrd unlabeled S-phase cells. This arrest could lead to overestimation of kinetic parameters such as S-phase transit time (Ts) and potential time (Tpot) as determined after in vivo labeling of tumors.

Bromodeoxyuridine

A macrolide antibiotic, roxithromycin, inhibits the growth of human myeloid leukemia HL60 cells by producing multinucleate cells.

The antiproliferative effect of roxithromycin (RXM) was studied using human myeloid leukemia HL60 cells. RXM inhibited the growth of HL60 cells in a concentration-dependent manner, and significantly inhibited growth at concentrations above 75 microM. This growth inhibition was not associated with specific cell cycle arrest and DNA synthesis was not impaired. In addition, the number of viable cells remained almost unchanged in the presence of 100 microM RXM. RXM induced growth inhibition at least partly by the formation of multinucleate cells. Both flowcytometric and morphological examination revealed that more than 40% of the RXM-treated cells were binucleate. These findings demonstrate that RXM is a potent new modulator of cell cycle progression in HL60 cells and suggest that the inhibition of cytokinesis by this drug may provide a new model for studying mitosis.

Bromodeoxyuridine